Washington HB 1224: Concerning prescription drug cost transparency.

Status: Effective date 7/28/2019. (as of 2019-05-09)

State: Washington · Session: 2019-2020 · Bill: HB 1224

Subjects: FINANCIAL MANAGEMENT, OFFICE, DRUGS, PUBLIC FUNDS AND ACCOUNTS, INSURANCE

Sponsors: Robinson, Appleton, Bergquist, Doglio, Frame, Gregerson, Jinkins, Lovick, Macri, Ortiz-Self, Peterson, Ryu, Slatter, Stanford, Tharinger, Wylie

View Washington HB 1224 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.